Vaxxinity
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Vaxxinity generated cash of -$57,238,000, which is less than the previous year. Cash used in financing activities reached the amount of -$1,140,000 last year. Net change in cash is therefore -$29,534,000.
Cash Flow
| 2019 | -12.26M | 0 | 11.13M |
|---|---|---|---|
| 2020 | -33.91M | -1.47M | 66.10M |
| 2021 | -80.99M | -1.31M | 196.16M |
| 2022 | -55.92M | -54.39M | -167K |
| 2023 | -57.23M | 28.84M | -1.14M |
VAXX Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 34.57M | 145.05M | 31.19M | 476K | 1.60M |
Operating activities | |||||
Net income | -56.93M | -75.22M | -137.17M | -39.95M | -14.21M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 2.23M | 1.68M | 1.10M | 717K | 107K |
Stock-based compensation expense | 7.50K | 8.71M | 30.41M | 1.01M | 1.22M |
| Deferred income tax benefit | 7.50K | 8.71M | 30.41M | 1.01M | 1.22M |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | -21K | 26K | -26K | -146K |
Inventories | 0 | 21K | 8.43M | -244K | 146K |
Accounts payable | -3.51M | 2.10M | 2.17M | -267K | -446K |
Cash generated by operating activities | -57.23M | -55.92M | -80.99M | -33.91M | -12.26M |
Investing activities | |||||
Purchases Of Investments | -63.94M | -107.52M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -803K | -1.86M | -1.31M | -1.47M | 0 |
Acquisitions Net | 0 | 52.52M | 0 | 0 | 0 |
Cash generated by investing activities | 28.84M | -54.39M | -1.31M | -1.47M | 0 |
Financing activities | |||||
Common Stock Issued | 454K | 263K | 71.07M | 59.81M | 17K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | -41K | 0 |
Repayments of term debt | -1.59M | -430K | -2.77M | -5.70M | 11.12M |
Cash used in financing activities | -1.14M | -167K | 196.16M | 66.10M | 11.13M |
Net Change In Cash | -29.53M | -110.48M | 113.85M | 30.72M | -1.12M |
Cash at end of period | 5.03M | 34.57M | 145.05M | 31.19M | 476K |
| Data source | Data source | Data source |